Medical Devices Accomplishments

 

A Leading Worldwide Supplier of Healthcare Products

Goal: To devise strategies for corporate investment in tissue engineering.

Results:

  • Identified and reviewed more than 150 tissue engineering research programs and methodologies.
  • Developed a short list of attractive opportunities in four clinical areas and organized two expert forums, consisting of 21 tissue engineering researchers and thought-leading physicians, to further vet these opportunities.
  • Recommended and justified two specific opportunities for investment, identified sources of applicable technologies and supported our client’s board presentation of our findings.

 

A Technology Driven Development-Stage Firm

Goal: To develop a partnering and licensing strategy for commercialization of a novel infection-control technology.

Results:

  • Positioned the client’s technology against existing methods based upon antiseptic coatings, subcutaneous cuffs, silver coatings, electrified catheters and other technologies.
  • Characterized eight areas of clinical application that could exploit our client’s technology.
  • Within each clinical realm, assessed the business opportunity as to economic potential, risk and commercialization timeline; recommended a preferred strategy appropriate to our client’s circumstances.

 

Worldwide Leader in Wound-Closure Products

Goal: Conduct a focused assessment of an already- successful industry competitor threatening our client’s $1.3 billion market position in surgical suture.

Results:

  • Profiled the competitive firm, a leader in less-invasive surgical products, in great detail and projected its sales revenues five years into the future.
  • Analyzed the competitor’s operations and thereby established the three critical factors responsible for its historic success.
  • Determined the competitor’s apparent strategies within each market segment.
  • Established the competitor’s initiatives related to its entry into the surgical suture business.
  • We recommended to our client that the competitor’s threatening initiative would fail, and that our client immediately pursue a diversification strategy in less-invasive surgical tools. 
  • Client followed both recommendations, and this strategy proved correct and profitable.

 

Emerging Supplier of Niche Products for Orthopedic Surgery

Goal: Position a prospective alliance partner in the field of bioresorbable technologies and products for orthopedic fixation.

Results:

  • Cataloged existing bioresorbable products, along with numerous technologies under development.
  • Developed commercialization profiles of five categories of bioresorbables, devised a projection of the likely commercial landscape, and estimated the positions of seven likely suppliers and the prospective alliance partner in bioresorbable devices.
  • Client acted on our advice to terminate alliance discussions and engaged specifically with other prospects.

 

University Spinout

Goal: Assist a pre-money university spinout offering a biosensor technology platform with business strategy, planning, opportunity assessment and industrial partnering initiatives.

Results:

  • Assessed the new company’s biosensor technology in comparison to those already commercialized and many others under development.
  • Identified and assessed the platform technology’s potential within four broad markets of opportunity: in vitro diagnostics, life science R&D, industrial microbiology, and chemical/biological defense.
  • Identified chemical and biological defense and industrial microbiology as offering the greatest, and most rapid, commercial potential and identified 26 prospective industrial and government funding partners from these sectors.
  • Recommended a near-term strategy combining outside focus (market understanding and assessment plus researching of prospective partner interests) and inside focus (broadening the technology’s demonstrable capabilities plus pursuing relevant grant funding of further development).

 

University Technology Transfer Center

Goal: Advise the client of the commercial potential of certain technologies for image-based plaque analysis of cardiovascular disease.

Results:

  • Identified and characterized three relevant existing markets: carotid imaging, coronary imaging, and abdominal and peripheral vascular imaging.  These sectors offered an aggregate worldwide available market of about $350 million.
  • Identified numerous prospective industrial partners – primarily scanner suppliers and imaging information system vendors – along with prospective competition.
  • Prioritized the three sectors and devised two alternative go-to-market monetization strategies: Quick technology out-licensing or an imaging service.